depression severity

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement

At 20 weeks, sequential CBTi+CPT produced significantly greater reductions in depression severity compared to Control+CPT. Approximately 46% of CBTi+CPT participants achieved depression remission comp

Effect: improvement